The Lancet Regional Health. Americas (Jul 2023)

Promises and perils of the FDA's over-the-counter naloxone reclassification

  • David T. Zhu,
  • Suzanne Tamang,
  • Keith Humphreys

DOI
https://doi.org/10.1016/j.lana.2023.100518
Journal volume & issue
Vol. 23
p. 100518

Abstract

Read online

No abstracts available.